Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin

52Citations
Citations of this article
27Readers
Mendeley users who have this article in their library.
Get full text

Abstract

The capacity of the immunomodulatory drug rapamycin (RAPA) to inhibit replication of the CCR5 strain of human immunodeficiency virus (HIV) in vitro prompted us to test its effects in a murine preclinical model of HIV infection. RAPA (0.6 or 6 mg/kg body weight) or its vehicle were administered daily, per os, to SCID mice reconstituted with human peripheral blood leucocytes (hu-PBL) starting 2 days before the intraperitoneal challenge with the R5 tropic SF162 strain of HIV-1 (1000 50% tissue culture infective dose/ml). Relative to hu-PBL-SCID mice that received no treatment, HIV-infected hu-PBL-SCID mice treated with the vehicle control for 3 weeks exhibited a severe depletion of CD4+ cells (90%), an increase in CD8+ cells and an inversion of the CD4+/CD8+ cell ratio. In contrast, treatment of HIV-infected mice with RAPA prevented a decrease in CD4+ cells and the increase of CD8+ cells, thereby preserving the original CD4+: CD8+ cell ratio. Viral infection also resulted in the detection of HIV-DNA within peritoneal cells and spleen, and lymph node tissues of the vehicle-treated mice within 3 weeks of the viral challenge. In contrast, treatment with RAPA decreased cellular provirus integration and reduced HIV-RNA levels in the blood. Furthermore, in co-cultivation assays, spleens from RAPA-treated mice exhibited a reduced capacity for infecting allogeneic T cells which was dose-dependent. These data show that RAPA possesses powerful anti-viral activity against R5 strains of HIV in vivo and support the use of additional studies to evaluate the potential application of this drug in the management of HIV patients. © 2008 British Society for Immunology.

References Powered by Scopus

Type I interferon as a powerful adjuvant for monocyte-derived dendritic cell development and activity in vitro and in Hu-PBL-SCID mice

580Citations
N/AReaders
Get full text

Akt-dependent regulation of NF-κB is controlled by mTOR and Raptor in association with IKK

533Citations
N/AReaders
Get full text

Efficacy of short-term monotherapy with maraviroc, a new CCR5 antagonist, in patients infected with HIV-1

461Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Pharmacological modulation of autophagy: Therapeutic potential and persisting obstacles

684Citations
N/AReaders
Get full text

Curcumin inhibits proliferation and promotes apoptosis of breast cancer cells

143Citations
N/AReaders
Get full text

Targeting autophagy in disease: established and new strategies

123Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Nicoletti, F., Lamenta, C., Donati, S., Spada, M., Ranazzi, A., Cacopardo, B., … Aquaro, S. (2009). Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin. Clinical and Experimental Immunology, 155(1), 28–34. https://doi.org/10.1111/j.1365-2249.2008.03780.x

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 10

56%

Researcher 8

44%

Readers' Discipline

Tooltip

Medicine and Dentistry 8

38%

Agricultural and Biological Sciences 7

33%

Biochemistry, Genetics and Molecular Bi... 3

14%

Immunology and Microbiology 3

14%

Save time finding and organizing research with Mendeley

Sign up for free